Cargando…

Anakinra for the Treatment of COVID-19-Associated Pericarditis: A Case Report

Detalles Bibliográficos
Autores principales:	Karadeniz, Hazan, Yamak, Betül Ayça, Özger, Hasan Selçuk, Sezenöz, Burak, Tufan, Abdurrahman, Emmi, Giacomo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2020
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391046/ https://www.ncbi.nlm.nih.gov/pubmed/32734502 http://dx.doi.org/10.1007/s10557-020-07044-3

Ejemplares similares

Venous inflammation might be one of the features of VEXAS syndrome and associated thrombosis
por: Karadeniz, Hazan, et al.
Publicado: (2023)

Early introduction of anakinra improves acute pericarditis and prevents tamponade in Staphylococcal sepsis
por: Sicignano, Ludovico Luca, et al.
Publicado: (2021)

The Prognostic Value of Lung Injury and Fibrosis Markers, KL-6, TGF-β1, FGF-2 in COVID-19 Patients
por: Karadeniz, Hazan, et al.
Publicado: (2022)

Efficacy of Anakinra in Pericarditis: A Systematic Review
por: Cheema, Ameer Haider, et al.
Publicado: (2022)

PW03-018 – Efficacy of Anakinra in recurrent pericarditis
por: Finetti, M, et al.
Publicado: (2013)

Could anakinra outmatch dexamethasone/tocilizumab in COVID-19?
por: Gupta, Rahul
Publicado: (2022)

Use of anakinra in the treatment of SARS-CoV-2 severe respiratory infection()
por: Figuero-Pérez, Luis, et al.
Publicado: (2023)

Use of Anakinra in steroid dependent recurrent pericarditis: a case report and review of literature
por: Thallapally, Vinay Kumar, et al.
Publicado: (2021)

Jaundice in a patient treated with Anakinra in a context of Covid-19
por: Tarhini, H., et al.
Publicado: (2021)

Anakinra or tocilizumab for prevention of COVID-19 death? A big dilemma
por: Patoulias, Dimitrios, et al.
Publicado: (2021)

Rilonacept and Anakinra in Recurrent Pericarditis: A Systematic Review and Meta-Analysis
por: Affas, Ziad R, et al.
Publicado: (2022)

Stenotrophomonas maltophilia pericarditis
por: Avşar, Cansu Bulut, et al.
Publicado: (2017)

Statistical models to predict clinical outcomes with anakinra vs. tocilizumab treatments for severe pneumonia in COVID19 patients
por: Piconi, Stefania, et al.
Publicado: (2023)

Regional Pericarditis or an Alternate Diagnosis?
por: Chhabra, Lovely, et al.
Publicado: (2014)

Safety and efficacy of early high-dose IV anakinra in severe COVID-19 lung disease
por: Pontali, Emanuele, et al.
Publicado: (2020)

Decreased exercise capacity, strength, physical activity level and quality of life in adult patients with familial Mediterranean fever
por: TORE, Nurten Gizem, et al.
Publicado: (2021)

Anakinra: a silver lining in COVID-19?
por: Gupta, Rahul
Publicado: (2020)

Myocarditis, pericarditis, and COVID-19 mRNA-vaccination
por: Sookaromdee, Pathum, et al.
Publicado: (2022)

Constrictive pericarditis complicating cardiac transplantation
por: Umer, Affan, et al.
Publicado: (2015)

Management of post-pericardiotomy constrictive pericarditis
por: Aldajani, Ahmed, et al.
Publicado: (2022)

Modified supraclavicular brachial plexus block for humerus fracture surgery: A report of two cases
por: Caliskan, Berna, et al.
Publicado: (2023)

Development of myocarditis and pericarditis after COVID‐19 vaccination: Comment
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Tubercular constrictive pericarditis after renal transplantation
por: Anitha, A., et al.
Publicado: (2015)

Massive purulent pericarditis in HIV-infected children
por: Joob, Beuy, et al.
Publicado: (2015)

The Use of IL-1 Receptor Antagonist (Anakinra) in Idiopathic Recurrent Pericarditis: A Narrative Review
por: Baskar, Shankar, et al.
Publicado: (2016)

Anakinra as a potential alternative in the treatment of severe acute respiratory infection associated with SARS-CoV-2 refractory to tocilizumab: comment()
por: Aomar-Millán, Ismael Francisco, et al.
Publicado: (2023)

Pericarditis secondary to COVID-19 infection in a kidney transplant recipient()
por: Sandino Pérez, Justo, et al.
Publicado: (2021)

A case of acute bacterial pericarditis in a COVID-19 patient
por: Lee, Pei Hua, et al.
Publicado: (2021)

Majeed syndrome: description of a novel mutation and therapeutic response to bisphosphonates and IL-1 blockade with anakinra
por: Roy, Noémi B A, et al.
Publicado: (2020)

Investigation of the value of hematological biomarkers in the clinical differential diagnosis of IgG4-RD
por: KARADENİZ, Hazan, et al.
Publicado: (2023)

Treatment with biologic DMARDs may not adversely affect lung nodules in rheumatoid arthritis patients
por: Karadeniz, Hazan, et al.
Publicado: (2022)

Hairy cell leukemia presenting with progressive pericarditis and pleuritis
por: Iwashige, Atsushi, et al.
Publicado: (2018)

Increased Mucosal IL-22 Production of an IL-10RA Mutation Patient Following Anakinra Treatment Suggests Further Mechanism for Mucosal Healing
por: Li, Jian, et al.
Publicado: (2017)

Heart rate variability in Eisenmenger syndrome and its correlation with echocardiographic parameters and plasma BNP, high sensitivity troponin-I level
por: Sezenöz, Burak, et al.
Publicado: (2017)

Prognostic value of interleukin-18 and its association with other inflammatory markers and disease severity in COVID-19
por: Satış, Hasan, et al.
Publicado: (2021)

Author’s Reply
por: Akın, Fatih, et al.
Publicado: (2016)

Use of multislice computed tomography in the diagnosis of annular constrictive pericarditis
por: Hochhegger, Bruno, et al.
Publicado: (2016)

Septal Bounce or Ventricle Interdependence in Constrictive Pericarditis: Same or Different
por: Agstam, Sourabh
Publicado: (2020)

Acute pericarditis in a young patient with IgG immunodeficiency
por: Skowerski, Tomasz, et al.
Publicado: (2020)

Efficacy of anakinra treatment in pediatric rheumatic diseases: Our single-center experience
por: Demir, Ferhat, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gd01bin7b4opc53q6l4n63nl47